Clinical Trials Browser

Arthritis, Rheumatoid, Breast Neoplasms, Coronary Disease, Depression, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Heart Failure, Obesity, Osteoporosis, Pulmonary Disease, Chronic Obstructive

NCT04680442 2025-04-06

SCHOLAR-2

Phase 2 Recruiting

130 enrolled

Breast

Breast Neoplasms, Heart Failure

NCT05465031 2025-03-14

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Phase 4 Recruiting

600 enrolled

Breast

Breast Diseases, Breast Neoplasms, Heart Failure, Neoplasms, Second Primary, Cardiotoxicity

NCT06304857 2024-12-04

PROTECTAA

Phase 3 Recruiting

188 enrolled

Breast

Breast Neoplasms, Heart Failure

NCT05851053 2024-05-29

BLOC-II

Recruiting

455 enrolled

Breast

Breast Neoplasms, Heart Failure, Ventricular Dysfunction, Cardiotoxicity

NCT05921279 2023-07-25

UCARE

Recruiting

100 enrolled

Breast

Breast Neoplasms, Heart Failure, Cardiomyopathies, Neoplasms, Cardiotoxicity

NCT05732051 2023-03-17

NARNIA

Phase 2 Recruiting

60 enrolled

Breast

Breast Neoplasms, Heart Failure, Cardiotoxicity

Clinical Trials

ML-CardioTox

TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

BE-FITTER

Alpaca

Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity

SCHOLAR-2

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

PROTECTAA

BLOC-II

UCARE

NARNIA